| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.49B | 35.35B | 34.18B | 31.21B | 29.52B | 26.95B |
| Gross Profit | 26.84B | 25.97B | 24.93B | 22.53B | 21.48B | 19.73B |
| EBITDA | 12.42B | 12.65B | 7.08B | 8.03B | 8.28B | 10.99B |
| Net Income | 7.08B | 7.04B | 3.12B | 6.14B | 2.28B | 5.26B |
Balance Sheet | ||||||
| Total Assets | 80.37B | 70.33B | 74.12B | 68.33B | 72.16B | 71.17B |
| Cash, Cash Equivalents and Short-Term Investments | 10.05B | 9.77B | 11.24B | 11.28B | 9.86B | 11.66B |
| Total Debt | 10.72B | 8.07B | 10.65B | 8.79B | 13.09B | 15.15B |
| Total Liabilities | 29.56B | 25.11B | 28.31B | 24.93B | 29.31B | 29.65B |
| Stockholders Equity | 50.30B | 44.73B | 45.44B | 43.16B | 40.13B | 38.85B |
Cash Flow | ||||||
| Free Cash Flow | 6.48B | 7.94B | 4.42B | 5.55B | 4.77B | 5.52B |
| Operating Cash Flow | 7.31B | 8.65B | 5.22B | 6.33B | 5.65B | 6.22B |
| Investing Cash Flow | -786.00M | -1.33B | -667.00M | 906.00M | 667.00M | -3.06B |
| Financing Cash Flow | -7.68B | -7.85B | -3.40B | -7.73B | -6.34B | -56.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $213.60B | 30.41 | 12.18% | 0.63% | 8.41% | 22.92% | |
73 Outperform | $134.60B | 69.92 | 15.49% | ― | 21.05% | 28.67% | |
71 Outperform | $149.91B | 36.89 | 21.99% | 0.64% | 17.14% | 41.18% | |
71 Outperform | $49.74B | 73.33 | 7.34% | ― | 13.35% | -60.76% | |
68 Neutral | $266.04B | 33.31 | ― | 1.07% | 11.85% | 167.23% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | $73.92B | -49.40 | -53.32% | ― | 28.48% | -19.12% |